Preparation of Gastrointestinal Symptoms Management and Anxiety Management Program in Breast Cancer Patients Receiving Chemotherapy: A Literature Review

Main Article Content

Phattra Ployngam
Benyaporn Bannaasan

Abstract

Introduction: This academic article discusses programs to prepare breast cancer patients receiving chemotherapy to reduce gastrointestinal symptoms and anxiety. Data was gathered from ThaiJO, Scopus, PubMed and EBSCO host from 2017 to 2023. Keyword searches included “breast cancer patient” and “chemotherapy” and “preparing program” and “gastrointestinal symptom cluster” and “nausea and vomiting” and “mucositis” and “anxiety”. Ten related research subjects were selected and analyzed. Results were that two theories were used as a framework for creating the program: 1) Orem's self-care theory and 2) symptom management theory. Program activities included pre-treatment of chemotherapy drugs, physical and mental chemotherapy, self-action education, non-pharmacological management activities, and phone follow up. The ten to fifty minute program sessions extended from one day to three months. Results were that physically, frequency and severity of nausea, vomiting, loss appetite, and mucositis decreased as well as mental anxiety levels. Conclusion: These programs can be used in the clinic to prepare patients by providing education on managing physical and psychological symptoms of chemotherapy in breast cancer patients receiving chemotherapy.

Article Details

How to Cite
Ployngam, P., & Bannaasan, B. . (2024). Preparation of Gastrointestinal Symptoms Management and Anxiety Management Program in Breast Cancer Patients Receiving Chemotherapy: A Literature Review. Journal of Research in Nursing-Midwifery and Health Sciences, 44(3), 69–83. Retrieved from https://he02.tci-thaijo.org/index.php/nur-psu/article/view/269458
Section
Articles

References

World Health Organization. Estimates number of new cases in 2022 [Internet]. Lyon: World Health Organization; 2022 [cited 2024 Apr 27]. Available from: https://gco.iarc.fr/today/data/factsheets/cancers/39-All-cancers-fact-sheet.pdf?fbclid=IwAR1tI3r2LHo0uLBBqcSHi3VV71FbI85bhTFOYWRIT-teV97Zsp1owjcOCwc

National Cancer Institute.Cancer in Thailand Vol.X, 2016-2018 [Internet]. Bangkok: National Cancer Institute; 2022 [cited 2024 Apr 20]. Available from: https://www.nci.go.th/e_book/cit_x/index.html

Jongkhetkit W, Promkaew P, Sumdang D. Gastrointestinal and fatigue symptom cluster management in patients with breast cancer receiving chemotherapy. MJSBH. 2019; 34(2): 217-30. Thai.

Ocharoenrat P, Yenbutra P, Prasert W, et al. Breast cancer. 1 st ed. Bangkok: BKKMEDJ; 2019. Thai.

Laoitthi P, Parainyanitikul N. Breast cancer: Epidemiology, prevention and screening recommendations. Chula Med J. 2016; 60(5): 497-507. Thai.

National Cancer Institute. Breast cancer treatment (adult) patient version [Internet]. Bangkok: National Cancer Institute; 2017 [cited 2024 Apr 20]. Available from: https://www.cancer.gov/types/breast/patient/breast-treatment-pdq

Suttiwanich S, Khampiew A. Comparison of nausea and vomiting among patients whose receiving antiemesis drug and antiemesis drug with ginger in cancer patients receiving AC and FAC formulations, Lopburi Cancer Hospital. J DMS. 2020; 45(4): 162-6. Thai.

Korpunsilp S, Pongmesa T. Quality of life of breast cancer women during chemotherapy with fluorouracil, doxorubicin and cyclophosphamide (FAC) regimen. Songkla Med J. 2017; 35(4): 373-84. Thai.

Potarin W, Saengthong W, Chaiyasit Y, et al. The role of nurses for promoting nutrition in cancer patients receiving chemotherapy. JMND. 2021; 8(9): 131-43. Thai.

Harris CS, Kober KM, et al. Symptom clusters in patients receiving chemotherapy: A systematic review. BMJ supportive & palliative care. 2022; 12(1): 10-21. doi: 10.1136/bmjspcare-2021-003325.

Jindakul P, Namvongprom A, Pakdevong N. Effectiveness of the educative-supportive program on self care ability, perceived intensity of side effects of chemotherapy and anxiety among patients with early breast cancer under-going adjuvant chemotherapy. Thai Cancer J. 2018; 38(3): 105-16. Thai.

Karomprat A, Chaichan P, Santawesuk U, et al. Symptoms, symptom management and outcome in cancer patients undergoing chemotherapy. Srinagarind Med J. 2017; 32(4): 326-31. Thai.

Roozegar MA, Nourmohammadi H, Havasian M, et al. Evaluation of oral and dental complications caused by cyclophosphamide in patients with breast cancer in the Shahid-Mostafa Hospital, Ilam, 2019. RJPTh. 2022;15(12):5517-20. doi: 10.52711/0974-360X.2022.00931.

National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines®): Antiemesis, version 2.2024 - September 27, 2024 [Internet]. Pennsylvania, PA: National Comprehensive Cancer Network; 2024 [cited 2024 Oct 16]. Available from: https://www.nccn.org/guidelines/category_1

Jamali J, Dayo A, Memon N, et al. Assessment of patient’s response about adverse drug reactions receiving AC (adriamycin, cyclophosphamide) therapy: A survey research. J Pharm Res Int. 2021; 33(26A): 8-13. doi: 10.9734/jpri/2021/v33i26A31467.

Nakamura ZM, Deal AM, Nyrop KA, et al. Serial assessment of depression and anxiety by patients and providers in women receiving chemotherapy for early breast cancer. Oncologist. 2021; 26(2): 147-56. doi: 10.1002/onco.13528.

Polit D, Beck C. Generating and assessing evidence for nursing practice. 11 th ed. Philadelphia, PA: Lippincott; 2021.

Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021; 372: n71. doi:10.1136/bmj.n71.

Handa S, Okuyama H, Yamamoto H, et al. Effectiveness of a smartphone application as a support tool for patients undergoing breast cancer chemotherapy: A randomized controlled trial. Clin Breast Cancer. 2020; 20(3): 201-8. doi: 10.1016/j.clbc.2020.01.004.

Soliman HM, Eltantawy A, El-Kurdy R. The effect of progressive muscle relaxation training on chemotherapy-induced nausea, vomiting and anxiety in Egyptian breast cancer women: A randomized controlled trial. JNEP. 2022; 12(4): 1. doi: 10.5430/jnep.v12n4p1.

Mahboobeh P, Sahar S, Seyed R, et al. The effect of music therapy on chemotherapy-induced nausea and vomiting in women with breast cancer. Indian Journal of Cancer. 2023; 60(1): 87-91. doi: 10.4103/ijc.IJC_535_19.

Araújo RV, Fernandes AFC, Campelo RCV, et al. Effect of Raja yoga meditation on the distress and anxiety levels of women with breast cancer. Religions. 2021; 12(8): 590. doi: 10.3390/rel12080590.

Juartika W. The effect of drinking cold water on nausea and vomiting among patient with post-chemotherapy breast cancer. JPNS. 2022; 1(3): 74-85. doi: 10.55048/jpns.v1i3.15.

ArbabiSarjou A, Khamar M, Sasanpour P, et al. The effect of self-care training on the severity of oral mucositis in breast cancer patients undergoing chemotherapy. Med Surg Nurs J. 2021; 10(4). doi: 10.5812/msnj.123386.

Mazraeh E, Sadighi S, Manifar S, et al. Assessment of thyme honey oral gel for the prevention of adriamycin and cyclophosphamide chemotherapy-induced oral mucositis in patients with breast cancer. Support Care Cancer. 2023; 31(8): 497. doi: 10.1007/s00520-023-07943-9.

Chinda M, Jaturapatporn D, Kirshen AJ, et al. Reliability and validity of a Thai version of the Edmonton Symptom Assessment Scale (ESAS-Thai). J Pain Symptom Manage. 2011; 42(6): 954-60. doi: 10.1016/j.jpainsymman.2011.02.020.

Kim TH, Choi BM, Chin JH, et al. The reliability and validity of the Rhodes index of nausea, vomiting and retching in postoperative nausea and vomiting. Korean J Anesthesiol. 2007; 52(6): S59-65. doi: 10.4097/kjae.2007.52.6.S59.

Natethong T, Hanucharumkul S, Rattamatharathorn V. The effects of ice-chips in the prevention and relief of oral mucositis in cancer patients receiving chemotherapy. Rama Nurs J. 2000; 6(3): 183-92. Thai.

Bjelland I, Dahl AA, Haug TT, et al. The validity of the hospital anxiety and depression Scale: An updated literature review. J Psychosom Res. 2002; 52(2): 69-77. doi: 10.1016/s0022-3999(01)00296-3.